Compare Organon & Co. Common Stock (OGN) vs Teradyne, Inc. (TER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs Teradyne, Inc. — how do they compare? Organon & Co. Common Stock trades at $13.73 (market cap $3.61B), while Teradyne, Inc. trades at $348.8 (market cap $56.20B). The key difference: Teradyne, Inc. is far larger — about 15.6× Organon & Co. Common Stock's market cap, and Organon & Co. Common Stock pays the higher dividend (0.58%). Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Teradyne, Inc. for 37 Days on average.
| OGN | TER | |
|---|---|---|
Market Cap | $3.61B | $56.20B |
Volume | 1,808,049 | 3,754,298 |
Sector | Health | Technology |
52-Week High | $13.81 | $483.84 |
52-Week Low | $5.70 | $138.09 |
Typical Hold Time | 0 Days | 37 Days |
Enterprise Value | $11.03B | $55.94B |
Dividend Yield | 0.58% | 0.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Teradyne (TER) trades at $380.29, down 0.93% on the day, with a bearish technical signal and support near $378. The stock shows strong fundamentals, beating earnings estimates in recent quarters, with a 25.77% net income margin and robust ROE of 36.66%. Recent news highlights expansion in AI-driven memory test solutions and strategic partnerships, positioning the company for growth in semiconductor equipment demand.
Outlook is positive with analyst consensus price target of $461.50, implying 21% upside, supported by 61% buy ratings. Risks include competitive pressures in semiconductor testing and reliance on cyclical tech spending. Earnings momentum and AI-driven demand present opportunities, but investors should monitor execution against high valuation multiples like a P/E of 52.24.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About Teradyne, Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →
